International Journal of Clinical Research
International Journal of Clinical Research. 2026; 10: (6) ; 10.12208/j.ijcr.20260280 .
总浏览量: 72
徐州矿务集团总医院 江苏徐州
*通讯作者: 乔伟,单位:徐州矿务集团总医院 江苏徐州; ;
目的 讨论及研究喜辽妥联合不同注射方法在改善阿扎胞苷皮下注射不良反应中的应用效果。方法选择2025年1月-2025年12月于我院接受阿扎胞苷的60例患者进行研究,随机数字表法分成对照组和实验组,每组30例,对照组常规注射,实验组区域轮换注射联合注射后喜辽妥涂抹,对比两组患者疼痛程度;不良反应发生率。结果 两组患者提供不同的干预措施后,实验组疼痛程度低于对照组,P<0.05,对比不良反应发生率,实验组更低,p<0.05。结论 为阿扎胞苷皮下注射的患者提供轮换区域皮下注射联合注射后涂抹喜辽妥,可以提升患者的舒适度,降低并发症的产生,值得提倡。
Objective To discuss and study the application effect of Xiliaotuo combined with different injection methods in improving the adverse reactions of azacitidine subcutaneous injection. Methods Sixty patients who received azacitidine in our hospital from January 2025 to December 2025 were selected for the study. They were randomly divided into the control group and the experimental group by the random number table method, with 30 cases in each group. The control group received routine injections, while the experimental group received regional rotation injections combined with Xiliaotuo application after injection. The pain levels of the two groups were compared. Incidence of adverse reactions. Results After providing different intervention measures to the two groups of patients, the pain degree in the experimental group was lower than that in the control group, P<0.05. In contrast, the incidence of adverse reactions in the experimental group was even lower, p<0.05. Conclusion For patients who receive subcutaneous injection of azacitidine, providing rotational area subcutaneous injection combined with application of Xiliaotuo after injection can enhance the comfort of patients and reduce the occurrence of complications, which is worthy of promotion.
[1] 黄梅真,杨洲芬.喜辽妥联合硫酸镁湿敷预防阿扎胞苷皮下注射所致局部皮肤反应的效果观察[J].黑龙江中医药,2025,54(1):60-62.
[2] 漆宁.地塞米松湿敷联合喜辽妥预防阿扎胞苷皮下注射所致不良反应的护理效果观察[J].保健文汇,2020(12): 101-102.
[3] 林艳,张瑞春,陈燕辉,蔡清华.喜辽妥联合改良式皮下注射阿扎胞苷对骨髓增生异常综合征患者皮肤不良反应的影响[J].福建医药杂志,2022,44(3):153-154.
[4] 陈喜填,李泳青,江宏彬,罗耿聪,郑小玲,夏维林.国产阿扎胞苷联合维奈托克治疗中高危骨髓增生异常综合征疗效观察[J].内科急危重症杂志,2024,30(4):346-347,374.
[5] 吴吕,刘芳.阿扎胞苷治疗中高危骨髓增生异常综合征的疗效及预后分析[J].临床合理用药杂志,2024,17(30):94-97.
[6] 龚菊萍,吴仲林,王淑芳.地西他滨与阿扎胞苷治疗骨髓增生异常综合征患者的临床疗效[J].当代医学,2024, 30(8):85-88.
[7] 魏丽莉,蔡惠兰,凌芳,郑云.止痛消炎软膏外敷联合喜辽妥治疗动静脉内瘘术后肢体瘀肿临床研究[J].新中医, 2023,55(23):110-114.
[8] 许雪芳.活血通络药酒联合喜辽妥在动静脉内瘘穿刺后修复护理中的应用效果[J].循证护理,2023,9(1):147-149.
[9] 朱玉莉,莫永灿,吕欢艳,王金宝,刘伟波.经皮腔内血管成形术联合喜辽妥治疗自体动静脉内瘘狭窄的疗效分析[J].中国现代药物应用,2023,17(13):135-138.
[10] 姚露.595nm可调脉宽脉冲染料激光联合超声波导入喜辽妥治疗烧伤后增生性瘢痕疗效分析[J].中国美容医学,2021,30(9):114-117.